NTB

Butterfield to Announce First Quarter 2024 Financial Results on April 23, 2024 and Host Earnings Conference Call on April 24, 2024

Retrieved on: 
Thursday, March 21, 2024

The Bank of N.T.

Key Points: 
  • The Bank of N.T.
  • Butterfield & Son Limited (“Butterfield”) (NYSE: NTB | BSX: NTB.BH) will release first quarter 2024 financial results following the close of the New York Stock Exchange on Tuesday, April 23, 2024.
  • Replay: An audio replay of the call will be available at https://www.butterfieldgroup.com/investor-relations/events-presentations for 12 months beginning April 24, 2024.

Butterfield Appoints General Counsel Following Retirement

Retrieved on: 
Friday, March 15, 2024

Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced the appointment of Simon Des-Etages to General Counsel and Group Chief Legal Officer effective March 18, 2024.

Key Points: 
  • Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced the appointment of Simon Des-Etages to General Counsel and Group Chief Legal Officer effective March 18, 2024.
  • Mr. Des-Etages succeeds Shaun Morris, who has served in the role for the last twelve years and made the decision to retire.
  • Mr Des-Etages then moved to Merrill Lynch, where he spent eight years working as a senior counsel in the Global Private Client Group.
  • He holds a Master of Laws (LLM) from University College London and a Bachelor of Laws from the University of Essex, UK.

HotelPlanner Partners with the Dutch Triathlon Association as the Official Accommodation Provider

Retrieved on: 
Thursday, March 7, 2024

The partnership includes a revenue share on member hotel bookings as their Official Accommodation Provider for all NTB events.

Key Points: 
  • The partnership includes a revenue share on member hotel bookings as their Official Accommodation Provider for all NTB events.
  • The NTB is affiliated with NOC*NSF, Europe Triathlon, and the World Triathlon and covers all combined endurance sports.
  • "We are thrilled to be partnering with the Dutch Triathlon Association, a sports leader in Europe, reaffirming our commitment to enhancing the travel process for the incredible multisport athletes who trust HotelPlanner for their accommodations," says Tim Hentschel, Co-Founder and CEO of HotelPlanner.
  • To all members of the NTB community, we extend a warm welcome to the HotelPlanner family."

Butterfield to Announce Fourth Quarter and Full Year 2023 Financial Results on February 12, 2024 and Host Earnings Conference Call on February 13, 2024

Retrieved on: 
Monday, January 29, 2024

The Bank of N.T.

Key Points: 
  • The Bank of N.T.
  • Butterfield & Son Limited (“Butterfield”) (NYSE: NTB | BSX: NTB.BH) will release fourth quarter and full year 2023 financial results following the close of the New York Stock Exchange on Monday, February 12, 2024.
  • Replay: An audio replay of the call will be available at https://www.butterfieldgroup.com/investor-relations/events-presentations for 12 months beginning February 13, 2024.

Butterfield Announces Senior Management Appointments

Retrieved on: 
Monday, January 15, 2024

Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced the promotion of Michael Neff to Group Chief Operating Officer.

Key Points: 
  • Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced the promotion of Michael Neff to Group Chief Operating Officer.
  • Mr. Neff, who has served as Managing Director of Bermuda and International Wealth since 2018 having joined Butterfield in 2011 as Group Head of Asset Management, takes responsibility for operations and technology across the Group.
  • At RiskMetrics, he initially served as Global Head of Wealth Management rising to become Co-Head of the firm’s Global Financial Risk Management business.
  • Mr. Dallas has extensive experience in marketing strategy and customer-led growth, and has led the marketing and communications functions at Butterfield since 2020.

KBW Announces Index Rebalancing for Fourth-Quarter 2023

Retrieved on: 
Saturday, December 9, 2023

NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for the fourth quarter of 2023.

Key Points: 
  • NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for the fourth quarter of 2023.
  • This quarter, there are constituent changes within four of our indexes: the KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Financial Technology Index (Index Ticker: KFTX, ETF Ticker: FTEK.LN), KBW Nasdaq Global Bank Index (Index Ticker: GBKX), and KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY).
  • As part of this rebalancing, below are the component-level changes across impacted indices:
    KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX; ETF Ticker: KBWD)
    Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI)
    Ares Commercial Real Estate Corporation (NYSE: ACRE)
    KKR Real Estate Finance Trust, Inc. (NYSE: KREF)
    Bank of N.T.
  • Butterfield & Son Limited (The) (NASDAQ: NTB)
    PennyMac Mortgage Investment Trust (NASDAQ: PMT)
    KBW Nasdaq Financial Technology Index (Index Ticker: KFTX, ETF Ticker: FTEK.LN)

Butterfield Announces Share Repurchase Program

Retrieved on: 
Tuesday, December 5, 2023

Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced that its Board of Directors has approved a $90 million ordinary share repurchase program (“the Share Repurchase Program”) pursuant to which the Bank is authorized to purchase up to 3.5 million of its ordinary shares through December 31, 2024.

Key Points: 
  • Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced that its Board of Directors has approved a $90 million ordinary share repurchase program (“the Share Repurchase Program”) pursuant to which the Bank is authorized to purchase up to 3.5 million of its ordinary shares through December 31, 2024.
  • Michael Collins, Chairman and Chief Executive Officer said: “I am pleased that the Board of Directors has approved a new Share Repurchase Program as the Bank continues to produce significant capital by generating strong risk adjusted returns.
  • Repurchases under the new Share Repurchase Program may be made in the open market or through privately negotiated transactions, including under US Securities & Exchange Commission Rule 10b5-1, and will be made in accordance with applicable laws and regulations.
  • The Share Repurchase Program will come into effect on December 15, 2023 with the termination of the current 3.0 million share repurchase program that was announced on February 13, 2023.

NeuroTrigger Received FDA 510(k) for that its non-invasive muscle stimulation system (NTB)

Retrieved on: 
Monday, October 30, 2023

RAANANA, Israel, Oct. 30, 2023 /PRNewswire/ -- NeuroTrigger is pleased to announce that its non-invasive muscle stimulation system (NTB) has been granted 510(k) clearance by the US Food & Drug Administration (FDA) for the prevention or retardation of disuse atrophy and muscle re-education to maintain or increase range of motion.

Key Points: 
  • RAANANA, Israel, Oct. 30, 2023 /PRNewswire/ -- NeuroTrigger is pleased to announce that its non-invasive muscle stimulation system (NTB) has been granted 510(k) clearance by the US Food & Drug Administration (FDA) for the prevention or retardation of disuse atrophy and muscle re-education to maintain or increase range of motion.
  • The NTB system is portable, rechargeable, aesthetic, and user-friendly and is composed of 3 elements: a stimulator, a daily use /disposable electrode, and a mobile App., which controls the system.
  • This NTB system is designed to stimulate muscles in a controlled rhythm with an option to personalize the stimulation parameters for each patient's needs.
  • Dr Nikolai Kunicher, NeuroTrigger CEO commented that "This FDA milestone is important as we develop the technology for different clinical applications.

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Event with Key Opinion Leaders

Retrieved on: 
Tuesday, October 17, 2023

AD is a disorder of cognition, not just memory and MCI and early AD are characterized by a variety of cognitive deficits.

Key Points: 
  • AD is a disorder of cognition, not just memory and MCI and early AD are characterized by a variety of cognitive deficits.
  • It has the advantage of investigating a broad range of cognitive domains acknowledged to be clinically meaningful measures of function.
  • reliability and validity, support its use as an outcome measure in treatment evaluation studies and for use in clinical practice.
  • Based on the results in the SAPHIR study in early AD patients, theta power has been selected as a key secondary endpoint in the VIVIAD study.

Butterfield to Announce Third Quarter 2023 Financial Results on October 24, 2023 and Host Earnings Conference Call on October 25, 2023

Retrieved on: 
Tuesday, October 10, 2023

The Bank of N.T.

Key Points: 
  • The Bank of N.T.
  • Butterfield & Son Limited (“Butterfield”) (NYSE: NTB | BSX: NTB.BH) will release third quarter 2023 financial results following the close of the New York Stock Exchange on Tuesday, October 24, 2023.
  • Replay: An audio replay of the call will be available at https://www.butterfieldgroup.com/investor-relations/events-presentations for 12 months beginning October 25, 2023.